The Effects of a Nurse-led Community-based Sailing Programme on Resilience of School-aged Children With Autism: An RCT
Launched by CHINESE UNIVERSITY OF HONG KONG · Jun 29, 2025
Trial Information
Current as of July 22, 2025
Not yet recruiting
Keywords
ClinConnect Summary
This clinical trial is studying whether a nurse-led sailing program can help improve the resilience—that is, the ability to cope with challenges—of children with autism who attend regular schools. The researchers also want to see if the sailing program can boost the children’s quality of life, self-esteem, mood, and social skills. To find out, they will compare children who take part in the sailing activities with those who do simple crafting activities that don’t involve emotional or personal discussions.
Children between 7 and 12 years old with a confirmed diagnosis of autism and who go to inclusive schools where students with and without autism learn together may be eligible. Participants must be able to understand and communicate in Chinese and complete questionnaires in that language. The sailing group will join a six-day program led by nurses, with four one-hour sessions each day, totaling 24 hours of sailing activities. The other group will spend the same amount of time doing crafting activities. Children with previous sailing experience or severe motion sickness won’t be able to join. This study is not recruiting yet but aims to see if this unique sailing program can provide meaningful benefits for children with autism.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Be between the ages of 7 and 12,
- • Have a confirmed diagnosis of ASD,
- • Be enrolled in an inclusive education school,
- • Possess the ability to complete the questionnaire in Chinese,
- • Be able to communicate in Chinese.
- Exclusion Criteria:
- • With sailing experience,
- • With a history of severe motion sickness symptoms.
About Chinese University Of Hong Kong
The Chinese University of Hong Kong (CUHK) is a prestigious research institution renowned for its commitment to advancing medical science and improving healthcare outcomes. As a clinical trial sponsor, CUHK leverages its extensive academic resources and interdisciplinary expertise to conduct innovative research that addresses critical health challenges. The university fosters collaboration among leading researchers, healthcare professionals, and industry partners, ensuring rigorous study design and implementation. CUHK is dedicated to upholding the highest ethical standards in clinical research, with a focus on translating findings into tangible benefits for patients and the broader community.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Patients applied
Trial Officials
Myrian Sze Nga Fan, MSc
Principal Investigator
Chinese University of Hong Kong
William Ho Cheung Li, PhD
Study Director
Chinese University of Hong Kong
Laurie Long Kwan Ho, PhD
Study Director
Chinese University of Hong Kong
Sek Ying Chair, PhD
Study Chair
Chinese University of Hong Kong
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported